Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In preclinical research environments, the individual components of REGENO Cartalax + TB-500 + BPC-157 have been studied for their interaction with nitric oxide-associated pathways, angiogenic signaling networks, cytoskeletal organization mechanisms, extracellular matrix-associated processes, and chondrocyte-related signaling systems
Many successful autoimmune treatments, including biologics like adalimumab (anti-TNF) and tocilizumab (anti-IL-6), work by directly neutralizing specific pro-inflammatory cytokines
If adverse drug reactions occur, contact your healthcare professional, pharmacist, or directly to the information database on adverse drug reactions (actions), including reports of drug ineffectiveness RSE on REM National Center for Expertise of Medicines and Medical Devices of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan additional information Composition of the medicinal product One bottle contains: active substance: reduced glutathione sodium salt 0.646 g, corresponds to 600 mg reduced glutathione one ampoule with solvent contains: water for injection Release form and packaging 0.646 g of the drug is placed in a transparent glass bottle, sealed with a rubber stopper and sealed with an aluminum cap
It was found that, as in the case of other xenobiotics, Ca 2+ influx plays an extremely important role in chromium (VI)-dependent toxicity [184]
US$ 29.80
US$ 26.36
US$ 21.22
US$ 23.00
